back to top
Friday, October 24, 2025

Roche’s Tecentriq Halves Recurrence, Death Risk in Stage 3 dMMR Colon Cancer

The Roche Tecentriq colon cancer Phase 3 trial reveals a striking 50% decrease in recurrence and mortality among stage 3 dMMR patients when added to chemotherapy—potentially reshaping adjuvant treatment protocols.
Latest
Recommended

Roche’s Tecentriq Halves Recurrence, Death Risk in Stage 3 dMMR Colon Cancer

The Roche Tecentriq colon cancer Phase 3 trial reveals a striking 50% decrease in recurrence and mortality among stage 3 dMMR patients when added to chemotherapy—potentially reshaping adjuvant treatment protocols.

South Africa Ramps Up Vaccinations as Foot-and‑Mouth Disease Spreads Across Provinces

The South Africa foot-and-mouth disease outbreak has extended to five provinces, prompting authorities to order over 900,000 vaccine doses and consider disaster-level response. Quarantine in major feedlots and export bans threaten the country’s cattle sector and beef exports.

Roche’s Tecentriq Halves Recurrence, Death Risk in Stage 3 dMMR Colon Cancer

The Roche Tecentriq colon cancer Phase 3 trial reveals a striking 50% decrease in recurrence and mortality among stage 3 dMMR patients when added to chemotherapy—potentially reshaping adjuvant treatment protocols.

South Africa Ramps Up Vaccinations as Foot-and‑Mouth Disease Spreads Across Provinces

The South Africa foot-and-mouth disease outbreak has extended to five provinces, prompting authorities to order over 900,000 vaccine doses and consider disaster-level response. Quarantine in major feedlots and export bans threaten the country’s cattle sector and beef exports.

U.S. COVID Vaccine Recommendations Cause Confusion Among Doctors and Insurers

The recent shifts in U.S. COVID vaccine recommendations by Health Secretary RFK Jr. and CDC have created confusion over who should get boosters and what insurers cover, especially for children and pregnant women. With insurers awaiting ACIP guidance ahead of the late‑June meeting, the healthcare system braces for uncertainty.

Join our community of SUBSCRIBERS and be part of the conversation.

To subscribe, simply enter your email address on our website or click the subscribe button below. Don't worry, we respect your privacy and won't spam your inbox. Your information is safe with us.

Roche’s Tecentriq Halves Recurrence, Death Risk in Stage 3 dMMR Colon Cancer

The Roche Tecentriq colon cancer Phase 3 trial reveals a striking 50% decrease in recurrence and mortality among stage 3 dMMR patients when added to chemotherapy—potentially reshaping adjuvant treatment protocols.

South Africa Ramps Up Vaccinations as Foot-and‑Mouth Disease Spreads Across Provinces

The South Africa foot-and-mouth disease outbreak has extended to five provinces, prompting authorities to order over 900,000 vaccine doses and consider disaster-level response. Quarantine in major feedlots and export bans threaten the country’s cattle sector and beef exports.

Roche’s Tecentriq Halves Recurrence, Death Risk in Stage 3 dMMR Colon Cancer

The Roche Tecentriq colon cancer Phase 3 trial reveals a striking 50% decrease in recurrence and mortality among stage 3 dMMR patients when added to chemotherapy—potentially reshaping adjuvant treatment protocols.

South Africa Ramps Up Vaccinations as Foot-and‑Mouth Disease Spreads Across Provinces

The South Africa foot-and-mouth disease outbreak has extended to five provinces, prompting authorities to order over 900,000 vaccine doses and consider disaster-level response. Quarantine in major feedlots and export bans threaten the country’s cattle sector and beef exports.

Join us today!

Get access to exclusive content

Are you ready to take your experience to the next level? Unlock a world of exclusive benefits by joining our premium content community. As a member, you'll gain access to a wealth of valuable resources, tailored specifically for you.